all AI news
Mana.bio unveiled AI-based LNP delivery platform
AI – AI-TechPark ai-techpark.com
Mana.bio’s first-of-its-kind AI platform discovers and optimizes novel, customizable LNPs for tissue-specific delivery of nucleic acid-based therapeutics and vaccines Led by a multidisciplinary team with expertise in drug delivery, nanotechnology, and machine learning, Mana.bio closes oversubscribed $19.5M seed funding from Andreessen Horowitz Bio + Health, Base4 Capital, NFX, LionBird, and Technion Institute of Technology...
The post Mana.bio unveiled AI-based LNP delivery platform first appeared on AI-TechPark.
acid ai ai platform andreessen horowitz bio capital delivery drug delivery expertise funding health institute kind machine machine learning nanotechnology nfx novel platform seed seed funding team technion technology therapeutics vaccines